Information Journal Paper
APA:
Copy. (2018). Inhibiting the NLRP3 inflammasome with methylene blue as treatment adjunct in myelodysplasia. FRONT ONCOL, 8(1), 280-280. SID. https://sid.ir/paper/757490/en
Vancouver:
Copy. Inhibiting the NLRP3 inflammasome with methylene blue as treatment adjunct in myelodysplasia. FRONT ONCOL[Internet]. 2018;8(1):280-280. Available from: https://sid.ir/paper/757490/en
IEEE:
Copy, “Inhibiting the NLRP3 inflammasome with methylene blue as treatment adjunct in myelodysplasia,” FRONT ONCOL, vol. 8, no. 1, pp. 280–280, 2018, [Online]. Available: https://sid.ir/paper/757490/en